Product Information
PROPAFENONE HCL 300 MG TAB is a generic product labeled by ANI Pharmaceuticals, Inc., priced at $0.3880 per EA under NDC 62559023201. Its NADAC has been published 594 times since May 20, 2015.
FDA first approved this application on Apr 23, 2004. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
300 mg/1
Manufacturer
ANI Pharmaceuticals, Inc.NDC
62559023201
Classification
Generic
Dosage Form
TABLET, COATED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
PROPAFENONE HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA076550FDA Approved
4/23/2004
TE Code
AB
On Market Since
3/31/2015
Pharmacological Classes
Price Statistics
The NADAC for PROPAFENONE HCL 300 MG TAB has been published 594 times since May 20, 2015, and over the history we have for it it has declined 57.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3880 per EA |
|---|---|
| All-time high | $1.0175 (Apr 13, 2016) |
| All-time low | $0.2331 (Nov 20, 2024) |
| 52-week high | $0.5292 |
| 52-week low | $0.3880 |
| Median price | $0.6004 |
| Average price | $0.6064 |
| Largest weekly change | -42.9% (Mar 20, 2024) |
| Weeks tracked | 594 |
| Tracking since | May 20, 2015 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Propafenone Hydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
ANI Pharmaceuticals, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Propafenone Hydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Antiarrhythmic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of PROPAFENONE HCL 300 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for PROPAFENONE HCL 300 MG TAB, manufactured by ANI Pharmaceuticals, Inc., is $0.3880 per EA (NDC 62559023201), effective Sep 30, 2026.
How has the price of PROPAFENONE HCL 300 MG TAB changed over time?
Over the history we have for it, the NADAC for PROPAFENONE HCL 300 MG TAB has declined 57.4%. It has been tracked across 594 weekly CMS publications since May 20, 2015.
What are the highest and lowest recorded NADAC prices for PROPAFENONE HCL 300 MG TAB?
Since May 20, 2015, the NADAC for PROPAFENONE HCL 300 MG TAB has ranged from a low of $0.2331 (Nov 20, 2024) to a high of $1.0175 (Apr 13, 2016), with a median of $0.6004 per EA.
Are there cheaper alternatives to PROPAFENONE HCL 300 MG TAB?
No other NADAC-published product currently shares the active ingredient and strength of PROPAFENONE HCL 300 MG TAB in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures PROPAFENONE HCL 300 MG TAB?
PROPAFENONE HCL 300 MG TAB (NDC 62559023201) is labeled by ANI Pharmaceuticals, Inc., and CMS classifies it as a generic product.